EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The potential effectiveness of far-UVC (222 nm) in preventing infections in long-term care facilities: a six-month nonrandomized controlled phase II trial

Mette Assenholm Kristensen, Emilie Hage Mogensen, Stine Yde Nielsen, Christian Kanstrup Holm

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)

DOI: 10.1017/ash.2026.10425 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives: The objectives of this study were to assess the potential effectiveness of far-UVC (222 nm) in reducing hospital-treated infections, antibiotic prescriptions, and mortality in long-term care facilities (LTCFs), as well as to evaluate the rationale for a future randomized controlled trial (RCT). Design: A six-month, nonrandomized, controlled, three-arm Phase II trial was conducted in LTCFs in Denmark. Facilities were allocated in a 10:1:1 ratio to usual care, far-UVC in common rooms, and far-UVC in common and residents’ rooms. The trial was conducted between November 2024 and April 2025. The primary outcome was LTCF-acquired infections treated in hospitals. Results: The study included 12 LTCFs with a total of 635 residents. In the usual care group (n = 470), 600 hospital-treated infections were identified with a incidence rate (IR) of 86.2 per 10,000 resident-days. In the common rooms group (n = 76), 12 infections were identified with a IR of 10.4 per 10,000 resident-days and an adjusted incidence rate ratio (aIRR) of 0.12 (95% CI: 0.04–0.34). In the common and residents’ rooms group (n = 89), 78 infections were identified with a IR of 59.1 per 10,000 resident-days and an aIRR of 0.69 (95% CI: 0.23–2.07). The aIRR for total antibiotic prescriptions was 0.52 (95% CI: 0.29–0.96) in the group with lamps in common rooms and 0.83 (95% CI: 0.50–1.37) in the group with lamps in common and residents’ rooms. Conclusions: Far-UVC potentially reduces hospital-treated infections and antibiotic prescriptions in LTCFs, but these results should be considered preliminary until confirmed by an RCT.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →